Benzinga | Apr 20, 2021 04:08PM EDT

QIAGEN Launches artus Prep&Amp Kit

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced the launch of the artus(r) SARS-CoV-2 Prep&Amp UM Kit which uses a liquid based sample preparation technology to simplify and increase COVID-19 testing throughput. The artus(r) SARS-CoV-2 Prep&Amp UM Kit has been CE-IVD registered for use in the European Union and other markets and an application for Emergency Use Authorization (EUA) has been submitted to the FDA, allowing commercialization via notification in the US.